300 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
Corporate Presentation March 2026
Financial Results, Press Release
Announces Leadership and Board Updates
Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance
Announces Preliminary THIRD Quarter 2025 Results and RAISES 2025 NET REVENUE GUIDANCE
Amended material disclosure
Completes Acquisition of Melinta Therapeutics and Announces New Leadership Team
News, Securities Holder Rights or Indentures
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
S-3ASR
RW
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRER14A
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload